Fujian Haixi Pharmaceuticals Co., Ltd.
Fujian Haixi Pharmaceuticals Co., Ltd.
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Assessment of the Safety and Efficacy of C019199 Plus Sintilimab in Participants With Advanced Solid Tumors | Solid Tumor | Active, not recruiting | Phase 1 / Phase 2 | 2025-11-28 | NCT06220318 | |
| Safety and Efficacy of Oral HX9428 Tablets in Subjects With Wet Age-related Macular Degeneration (wAMD) | Wet Age-related Macular Degeneration (AMD) | Recruiting | Phase 1 / Phase 2 | 2025-09-25 | NCT07185841 |